Showing 2731-2740 of 4012 results for "".
- Machine Learning Model Flags HS Up to Two Years Before Diagnosis: Reporthttps://reachmd.com/news/machine-learning-model-flags-hidradenitis-suppurativa-up-to-two-years-before-diagnosis/2474208/A machine learning model analyzing U.S. insurance claims data was able to predict hidradenitis suppurativa (HS) up to two years before formal diagnosis, a new study shows. "Because the individual symptoms of cysts and abscesse
- Multi-Objective Deep Learning: Enhancements in Lung Cancer Detectionhttps://reachmd.com/news/multi-objective-deep-learning-enhancements-in-lung-cancer-detection/2474149/A new wave of artificial intelligence is advancing lung cancer diagnostics, bringing greater speed, precision, and nuance to CT imaging. At the forefront is multi-objective deep learning—a sophisticated approach that simultaneously hones in on tumor classification,
- Pelthos Therapeutics and Channel Therapeutics to Mergehttps://reachmd.com/news/pelthos-therapeutics-and-channel-therapeutics-to-merge/2474190/Ligand Pharmaceuticals has announced a definitive merger agreement that will combine its wholly owned subsidiary Pelthos Therapeutics with Channel Therapeutics Corporation, forming a publicly traded company under the name Pelthos Therapeutics Inc. The deal is suppo
- Unveiling Early Genetic Mutations in Stomach Cancer: A New Frontier in Diagnosis and Treatmenthttps://reachmd.com/news/genetic-mapping-early-mutations-in-stomach-cancer/2474157/A team of researchers at the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has made a significant leap forward in stomach cancer research by using sophisticated genetic mapping techniques to pinpoint early mutations that could signal the disease's
- Recalibrating Return-to-Sport Decisions After ACL Reconstruction: A Neuromuscular Perspectivehttps://reachmd.com/news/assessment-of-neuromuscular-impairments-for-return-to-sport-decision-making-post-acl-reconstruction/2474144/For athletes recovering from anterior cruciate ligament reconstruction (ACLR), the road back to competitive play is far from linear. Despite surgical advancements and structured rehabilitation protocols, neuromuscular impairments remain a formidable barrier to full
- The Role of Tumor DNA in Predicting Melanoma Recurrencehttps://reachmd.com/news/the-role-of-tumor-dna-in-predicting-melanoma-recurrence/2474173/A pioneering blood test that detects circulating tumor DNA (ctDNA) has emerged as essential in foreseeing melanoma recurrence. Designed for high‐risk stage III patients, this advancement enables healthcare professionals to discern early
- Protein Misfolding in Neurodegeneration: Insights from AI Toolshttps://reachmd.com/news/protein-misfolding-in-neurodegeneration-insights-from-ai-tools/2474176/RibbonFold elucidates the pathway through which pathological proteins assume aberrant structures, forming detrimental amyloid fibrils. These revelations augment our comprehension of neurodegenerative processes, equipping healthcare professionals with crucial insigh
- Genetic Testing in Hereditary Tumor Syndromes: Ethical, Psychosocial, and Legal Considerationshttps://reachmd.com/news/genetic-testing-in-hereditary-tumor-syndromes-ethical-psychosocial-and-legal-considerations/2474143/As next-generation sequencing (NGS) continues to transform the landscape of genomic medicine, its growing application in diagnosing hereditary tumor syndromes marks a major leap forward in personalized healthcare. From earlier detect
- Early Risk, Better Outcomes: How Stratification Is Redefining Chronic Care in Primary Practicehttps://reachmd.com/news/population-risk-stratification-chronic-disease-management-in-primary-care/2474072/In the evolving landscape of primary care, the integration of population risk stratification tools is emerging as a quiet but transformative force in chronic disease management. Rather than waiting for conditions to worsen, clinicians are now increasingly
- Osteoarthritis and the Genomic Frontier: Charting a Path Toward Disease-Modifying Therapieshttps://reachmd.com/news/osteoarthritis-and-the-genomic-frontier-charting-a-path-toward-disease-modifying-therapies/2474071/Osteoarthritis, long regarded as an inevitable consequence of aging, is emerging in a new light—one illuminated by breakthroughs in genomic science. Affecting an estimated 595 million people worldwide, the disease is not only the most prevalent form of arthritis bu